3 employees
Varient accelerates both the symptom management journey for people with rare genetic diseases and the treatment development journey for R&D.
2022
$50K
from 2 investors over 2 rounds
varient raised undisclosed on December 8, 2022
Investors: PharmStars
varient raised $50K on January 1, 2022
Investors: Right Side Capital Management